Full Description
To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24-25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Table of Contents
Front Matter
Proceedings of a Workshop
Appendix A: Statement of Task
Appendix B: Workshop Agenda
-
- 電子書籍
- トーラス
-
- 電子書籍
- カレフォン 分冊版(12) 最終話 私…